Antiretroviral therapy.
Research into the biology of human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome, has yielded valuable information about the replicative cycle of the virus. The steps involved are (1) attachment of the virus to a receptor protein on the surface of the target cell, (2) entry of the virus into the cell, (3) replication of the viral genome through a DNA intermediary, (4) entry of proviral DNA into the nucleus of the host cell, (5) integration of proviral DNA into the host cell genome, (6) transcription of proviral DNA to viral genomic and messenger RNA, (7) translation of viral messenger RNA to viral proteins, and (8) assembly of viral components into new virions that are released by budding from the host cell membrane. Each step in the HIV-1 replicative cycle offers a potential target for antiviral chemotherapy. Although many drugs have been developed, none appears singularly effective against all stages of HIV-1 infection. Many obstacles remain in the quest for an effective vaccine against HIV-1.
Thiers
B H
BH
Department of Dermatology, Medical University of South Carolina, Charleston 29425-2215.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D000998:Antiviral Agents / Q000627:therapeutic use*; D006678:HIV / Q000276:immunology / Q000502:physiology*; D006801:Humans; D012192:Retroviridae Infections / Q000188:drug therapy; D014765:Viral Vaccines / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D014765:Viral Vaccines